|
Back to products
Browse products
Approved anticancer agents
Anticancer agents in trials
Anticancer agents
in preclinical trials
Anticancer molecular libraries
Other drug agents
Drug intermediates
Bio-reagents and biochemicals
|
MedKoo product information:
Golotimod
Description of Golotimod: Golotimod is an orally
bioavailable synthetic peptide containing the amino acids
D-glutamine and L-tryptophan connected by a gamma-glutamyl linkage
with potential immunostimulating, antimicrobial and antineoplastic
activities. Although the exact mechanism of action is unknown,
golotimod appears to inhibit the expression of STAT-3, reversing
immunosuppression and stimulating an anti-tumor immune response.
This agent may stimulate the production of T-lymphocytes (in
particular the helper T [Th1] cells), activate macrophages, and
increase levels of interleukin 2 and interferon gamma. STAT-3, a
transcription factor upregulated in many cancer cell types, is
involved in tumor cell growth and survival and immunosuppression.
Check for
active clinical trials or
closed clinical trials using this agent. (NCI
Thesaurus)
Current developer: SciClone
Pharmaceuticals
|
MedKoo Code#:
201442
|
|
Name:
Golotimod
|
|
CAS#: 229305-39-9
Synonym: SCV 07;
gamma-D-glutamyl-L-tryptophan.
IUPAC/Chemical name:
(R)-2-amino-5-(((S)-1-carboxy-2-(1H-indol-3-yl)ethyl)amino)-5-oxopentanoic
acid
|
|
Chemical structure:
|
Theoretical analysis
|
|

|
Chemical Formula: C16H19N3O5
Exact Mass: 333.13247
Molecular Weight: 333.34
Elemental Analysis: C, 57.65; H, 5.75; N,
12.61; O, 24.00
|
|
Availability and price:
This product is available through custom synthesis.
To inquire the quotation and lead time of custom synthesis for this agent, please send email to
sales@medkoo.com to describe your needs. A representative
will respond your email shortly. We offer big discount for orders of bulk quantities.
|
|
Quality control
data:
Product will be shipped with
supporting analytical data.
|
|
Information about this agent
|
Golotimod
(SCV-07) is currently developed by SciClone Pharmaceuticals. According to
Sciclone's website,
This agent appears to stimulate the immune system through inhibition of
STAT3 signaling and the resulting effects on T-helper 1 cells. SCV-07
has been shown to be efficacious in animal models of immune-sensitive
diseases, including OM prevention, treatment of viral infections and
cancers, and in the enhancement of response to vaccines. SciClone has
exclusive worldwide rights to SCV-07 outside of Russia, where the
molecule has recently been approved for stimulation of depressed immune
systems.
1. Sharma, Geeta; Altmeyer, Ralf; Pendharker, Vishal;
Chen, Yu; Foley, Michael. Compositions and methods for treating viral
infections. U.S. Pat. Appl. Publ. (2010), 38pp. CODEN: USXXCO US
2010081713 A1 20100401 CAN 152:422252 AN 2010:409307
2. Rios, Israel; Tuthill, Cynthia W. Treatment or prevention of
hepatitis C with immunomodulator compounds. PCT Int. Appl. (2010), 20pp.
CODEN: PIXXD2 WO 2010017178 A1 20100211 CAN 152:231192 AN 2010:179070
3. Hausman, Diana F.; Dodds, Michael G. Use of PEGylated type III
interferons for the treatment of hepatitis C. PCT Int. Appl. (2009),
95pp. CODEN: PIXXD2 WO 2009149377 A1 20091210 CAN 152:55951 AN
2009:1536376
4. Tu, Chun-Yan; Wu, Yan-Jiao; Yuan, Yan-Juan; Yao, Zhong; Tang, Mei-Hua;
Wei, Pin. Analysis of -D-glutamyl-L-tryptophan in enzymatic synthesis
procedure by high performance liquid chromatography. Fenxi Huaxue
(2009), 37(10), 1528-1530. CODEN: FHHHDT ISSN:0253-3820. CAN 152:486059
AN 2009:1424015
5. Silin, Dmytro S.; Lyubomska, Oksana V.; Ershov, Feliks I.; Frolov,
Valeriy M.; Kutsyna, Galyna A. Synthetic and natural immunomodulators
acting as interferon inducers. Current Pharmaceutical Design (2009),
15(11), 1238-1247. CODEN: CPDEFP ISSN:1381-6128. CAN 150:396166 AN
2009:461115
6. Tuthill, Cynthia W. Immunomodulator compounds for the treatment of
lung cancer. PCT Int. Appl. (2009), 97pp. CODEN: PIXXD2 WO 2009025830 A1
20090226 CAN 150:229680 AN 2009:237937
7. Kolobov, Alexandr A.; Simbirtsev, Andrey S. Treatment of allergic
disease with immunomodulator compounds. PCT Int. Appl. (2008), 47pp.
CODEN: PIXXD2 WO 2008143824 A1 20081127 CAN 149:570720 AN 2008:1448400
8. Rose, William A.; Tuthill, Cynthia; Pyles, Richard B. An
immunomodulating dipeptide, SCV-07, is a potential therapeutic for
recurrent genital herpes simplex virus type 2 (HSV-2). International
Journal of Antimicrobial Agents (2008), 32(3), 262-266. CODEN: IAAGEA
ISSN:0924-8579. CAN 149:346806 AN 2008:1028482
9. Rios, Israel; Tuthill, Cynthia. Immunomodulator for treating or
preventing mucosa diseases in radiation induced hamster model. PCT Int.
Appl. (2008), 70pp. CODEN: PIXXD2 WO 2008100458 A2 20080821 CAN
149:259474 AN 2008:1009777
10. Wang, Qian; Yao, Zhong; Xun, Zhi-jin; Xu, Xiao-ying; Xu, Hong; Wei,
Ping. Properties and catalytic mechanism of -glutamyltranspeptidase
from B. subtilis NX-2. Gaoxiao Huaxue Gongcheng Xuebao (2008), 22(2),
288-293. CODEN: GHGXEG ISSN:1003-9015. CAN 150:185279 AN 2008:579366
11. Johansen, Lisa M.; Owens, Christopher M.; Mawhinney, Christina;
Chappell, Todd W.; Brown, Alexander T.; Frank, Michael G.; Altmeyer,
Ralf. Compositions and methods for treatment of viral diseases. PCT Int.
Appl. (2008), 237pp. CODEN: PIXXD2 WO 2008033466 A2 20080320 CAN
148:394354 AN 2008:352859
12. Wang, Qian; Yao, Zhong; Wu, Minggang; Xun, Zhijin; Zhou, Zhi; Xu,
Hong; Wei, Ping. Kinetic model of enzymatic synthesis of -D-glutamyl-L-tryptophan.
Huagong Xuebao (Chinese Edition) (2008), 59(2), 431-436. CODEN: HUKHAI
ISSN:0438-1157. CAN 148:401424 AN 2008:171837
13. Tuthill, Cynthia W.; Rudolph, Alfred R. Immunomodulators for the
treatment of melanoma. PCT Int. Appl. (2007), 36 pp. CODEN: PIXXD2 WO
2007123847 A2 20071101 CAN 147:462257 AN 2007:1237472
14. Tuthill, Cynthia W.; Rudolph, Alfred R. Immunomodulator compounds as
vaccine enhancers. PCT Int. Appl. (2006), 52pp. CODEN: PIXXD2 WO
2006116053 A1 20061102 CAN 145:469938 AN 2006:1153716
15. Tuthill, Cynthia W.; Rudolph, Alfred R. Treatment or prevention of
genital viral infections with immunomodulator compounds. PCT Int. Appl.
(2006), 16 pp. CODEN: PIXXD2 WO 2006076169 A2 20060720 CAN 145:117367 AN
2006:710748
16. Mossel, Eric C.; Tuthill, Cynthia W.; Rudolph, Alfred R. Treatment
or prevention of hemorrhagic viral infections with peptidic
immunomodulator compounds. PCT Int. Appl. (2006), 16 pp. CODEN: PIXXD2
WO 2006047702 A2 20060504 CAN 144:425658 AN 2006:411983
17. Aspinall, Richard J.; Pockros, Paul J. SCV-07(SciClone
Pharmaceuticals/Verta). Current Opinion in Investigational Drugs
(Thomson Scientific) (2006), 7(2), 180-185. CODEN: COIDAZ
ISSN:1472-4472. CAN 145:179912 AN 2006:211289
18. Tuthill, Cynthia W.; Rudolph, Alfred R.; Kolobov, Alexander A.;
Simbirtsev, Andrey S.; Petrov, Aleksandr V. Treatment or prevention of
respiratory viral infections with immunomodulator compounds. PCT Int.
Appl. (2005), 12 pp. CODEN: PIXXD2 WO 2005112639 A2 20051201 CAN
143:472545 AN 2005:1260987
19. Suzuki, Hideyuki; Kato, Kenji; Kumagai, Hidehiko. Development of an
efficient enzymatic production of -D-glutamyl-L-tryptophan (SCV-07), a
prospective medicine for tuberculosis, with bacterial -glutamyltranspeptidase.
Journal of Biotechnology (2004), 111(3), 291-295. CODEN: JBITD4
ISSN:0168-1656. CAN 141:294728 AN 2004:557823
20. Kolobov, Alexander A.; Simbirtsev, Andrey S.; Pigareva, Natalia V.;
Zabolotnych, Natalia V.; Vinogradova, Tat'yana I.; Kotov, Alexander Y.;
Tuthill, Cynthia; Rudolph, Alfred R. Biological activity of the
immunomodulatory peptide SCV-07 against murine tuberculosis. Peptides
2002, Proceedings of the European Peptide Symposium, 27th, Sorrento,
Italy, Aug. 31-Sept. 6, 2002 (2002), 536-537. CODEN: 69EYXG CAN
141:81715 AN 2004:28554
21. Kolobov, Alexander; Simbirtsev, Andrey; Pigareva, Natalia; Kolodkin,
Nikolay; Rudolph, Alfred; Tuthill, Cynthia. Further investigation of
immunomodulatory properties of gamma-glutamyl containing peptides.
Peptides 2000, Proceedings of the European Peptide Symposium, 26th,
Montpellier, France, Sept. 10-15, 2000 (2001), Meeting Date 2000,
877-878. CODEN: 69EDWK CAN 139:83623 AN 2003:509794
22. Simbirtsev, Andrey; Kolobov, Alexander; Zabolotnych, Natalia;
Pigareva, Natalia; Konusova, Valentina; Kotov, Alexander; Variouchina,
Elena; Bokovanov, Vladimir; Vinogradova, Tatyana; Vasilieva, Svetlana;
Tuthill, Cynthia. Biological activity of peptide SCV-07 against murine
tuberculosis. Russian Journal of Immunology (2003), 8(1), 11-22. CODEN:
RJIUAC ISSN:1028-7221. CAN 140:9493 AN 2003:497353
23. Kolobov, Alexander A.; Simbirtsev, Andrey S.; Kolodkin, Nikolay I.;
Pigareva, Natalia V.; Rudolph, Alfred R.; Tuthill, Cynthia.
Immunomodulatory properties of gamma-glutamyl and beta-aspartyl
containing peptides. Peptides 1998, Proceedings of the European Peptide
Symposium, 25th, Budapest, Aug. 30-Sept. 4, 1998 (1999), Meeting Date
1998, 526-527. CODEN: 68WKAY CAN 133:348860 AN 2000:288600
24. Bayes M; Rabasseda X; Prous J R Gateways to clinical trials. Methods
and findings in experimental and clinical pharmacology (2003), 25(5),
387-408. Journal code: 7909595. ISSN:0379-0355. PubMed ID 12851663 AN
2003321640
25. May Thomas S Cold war adversaries team up to conquer TB. Drug
discovery today (2002), 7(23), 1149-50. Journal code: 9604391.
ISSN:1359-6446. PubMed ID 12547010 AN 2003039725
26. Orellana Claudia Immune system stimulator shows promise against
tuberculosis. The Lancet infectious diseases (2002), 2(12), 711. Journal
code: 101130150. ISSN:1473-3099. PubMed ID 12467673 AN 2002706831
|
Contact MedKoo:
Email:
sales@medkoo.com
(Keyword; CAS#; MedKoo code#)
|